𝔖 Bobbio Scriptorium

✦ LIBER ✦

PDB7 LONGTERM HEALTH OUTCOMES IN NEWLY DIAGNOSED TREATMENT NAï VE TYPE 2 DIABETES PATIENTS INITIATED WITH BIPHASIC INSULIN ASPART IN CHINA: DATA FROM THE IMPROVE STUDY

✍ Scribed by J White; M Aagren; L Jing

Book ID: 119597504
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 78 KB
Volume: 11
Category: Article
ISSN: 1098-3015
DOI: 10.1016/s1098-3015(10)66654-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PDB35 COST-UTILITY ANALYSIS OF BIPHASIC

PDB35 COST-UTILITY ANALYSIS OF BIPHASIC INSULIN ASPART VERSUS HUMAN INSULIN IN TYPE 2 DIABETES MELLITUS PATIENTS TREATED IN TIER III HOSPITALS IN BEIJING, CHINA: A LONGTERM OUTCOMES MODEL EVALUATION FROM THE IMPROVE OBSERVATIONAL STUDY

✍ J White; M Aagren; L Jing 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB

PDB34 Improvements in Quality of Life As

PDB34 Improvements in Quality of Life Associated With Biphasic Insulin Aspart 30 in Type 2 Diabetes Patients in China: Results from the A1Chieve Observational Study

✍ Yang, W.Y.; Shi, Y.Q.; Li, Y.K.; Wang, Y.; Li, Y.X. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB

P-27 Treatment with biphasic insulin asp

P-27 Treatment with biphasic insulin aspart 30 improves glycaemic control in patients with Type 2 diabetes inadequately controlled with oral antidiabetic drugs: results from China cohort in the PRESENT study

✍ Yan Gao 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 93 KB

DB1 EVALUATING THE COST-EFFECTIVENESS OF

DB1 EVALUATING THE COST-EFFECTIVENESS OF THERAPY CONVERSION FROM BASAL INSULIN TO BIPHASIC INSULIN ASPART 30/70 IN PATIENTS WITH TYPE 2 DIABETES IN CHINA: A MODELING STUDY OF LONG-TERM COSTS AND HEALTH OUTCOMES

✍ Chang, J; Sun, F; Li, H 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB